Leading stem cell and exosome therapy research blog by Cell La Vie, Bangkok. Clinical insights, cost breakdowns, and regenerative treatment guides.
Traveling abroad for stem cell therapy is a transformative step. Patients seek innovative treatments for conditions like arthritis, neurological disorders, or chronic injuries. At Cell La Vie in Thailand, we offer world-class care. We guide international patients through this journey with safety and support. This comprehensive guide explains what to expect when traveling for stem […]
Read More »Discover the essential 5 questions to ask before embarking on Stem Cell Treatment. Get the insights you need to make informed decisions and ensure a successful experience. Don’t miss out on this crucial information!
Read More »One of the most frequent clinical questions patients ask before undergoing regenerative treatment is whether receiving donor stem cells requires blood typing (ABO and Rh factor matching) or cross-matching, similar to a blood transfusion or organ transplant. If you have blood type O-negative, A-positive, or AB-positive, do you need donor cells that match your exact […]
Read More »MSCs are the most promising cell therapy in progressive MS, and 2026 added the mechanism papers and one well-controlled trial that finally make the case. Here’s what 17 trials, SMART-MS, and the new miRNA work mean for real patients.
Read More »Eight 2026 studies detail how MSC exosomes inhibit ferroptosis, deliver sustained paracrine signaling via hydrogels, and improve LVEF in rat MI models. Here is what translational researchers need to know before the first Phase 2 exosome trial reads out.
Read More »Discover the groundbreaking potential of MSC-derived exosomes in revolutionizing Rheumatoid Arthritis immunotherapy. Learn about novel nanoplatforms and their mechanism of action.
Read More »2026 medical update on MSC therapy for diabetic foot ulcers: M2 macrophage polarization, EXO-miR3671 angiogenesis, hydrogel delivery, UC-MSC vs ADSC head-to-head, 47-RCT meta-analysis, and cost-effectiveness vs amputation in Thailand.
Read More »2026 Q3 update on allogeneic vs autologous MSC: head-to-head trial data, donor-age impact, 2026 manufacturing advances, when each is preferred, the cost picture, and FAQ for patients in Thailand and Asia-Pacific.
Read More »Osteoporosis after menopause affects millions of women. New 2026 research shows mesenchymal stem cells and exosomes can rebuild bone density safely. Here’s what patients need to know.
Read More »If you or someone you love is living with ALS (Amyotrophic Lateral Sclerosis), you already know the hardest part of the diagnosis: being told to wait. Wait for research. Wait for trials. Wait for something to change. But something is changing — and it’s happening faster than many people realize. Around the world, researchers are exploring a […]
Read More »Explore the latest 2026 research on stem cell therapy for dry Age-Related Macular Degeneration (AMD). Learn how RPE cell transplantation and clinical trials offer new hope for restoring vision. Consult Cell La Vie.
Read More »New 2026 research reveals UC-MSC exosomes combined with low-intensity pulsed ultrasound and curcumin-hydrogel systems achieve remarkable burn wound healing — including MRSA-infected wounds — through autophagy regulation, anti-scarring mechanisms, and immunomodulation. Five landmark papers reviewed.
Read More »2026 patient guide to MSC therapy for Alzheimer’s disease: how it differs from lecanemab and donanemab, who is a candidate, what outcomes to expect, the 6 active clinical trials including NCT06775964 and the first MSC + antibody drug combination trial.
Read More »